Serum Calcification Propensity and Clinical Events in CKD
Author(s) -
Joshua D. Bundy,
Xuan Cai,
Rupal Mehta,
Julia J. Scialla,
Ian H. de Boer,
Chiyuan Hsu,
Alan S. Go,
Mirela Dobre,
Jing Chen,
Panduranga S. Rao,
Mary B. Leonard,
James P. Lash,
Geoffrey A. Block,
Raymond R. Townsend,
Harold I. Feldman,
Edward R. Smith,
Andreas Pasch,
Tamara Isakova
Publication year - 2019
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.04710419
Subject(s) - medicine , hazard ratio , proportional hazards model , cardiology , kidney disease , myocardial infarction , heart failure , confidence interval , prospective cohort study , stroke (engine) , mechanical engineering , engineering
Patients with CKD are at high risk for cardiovascular disease, ESKD, and mortality. Vascular calcification is one pathway through which cardiovascular disease risks are increased. We hypothesized that a novel measure of serum calcification propensity is associated with cardiovascular disease events, ESKD, and all-cause mortality among patients with CKD stages 2-4.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom